Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

SCLXW Company Profile and Key Details

NASDAQ : SCLXW

Scilex

$0.50
0.0776+18.41%
Open: 11:41 AM
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Scilex Holding Company (SCLXW) stock surged +18.41%, trading at $0.50 on NASDAQ, up from the previous close of $0.42. The stock opened at $0.50, fluctuating between $0.50 and $0.50 in the recent session.

Stock Snapshot

0.4216
Prev. Close
130.79M
Market Cap
0.4967
Day Low
N/A
P/E Ratio
N/A
EPS (TTM)
-0.21
Cash Flow per Share
0.5
Open
262.01M
Number of Shares
0.4992
Day High
73.54%
Free Float in %
-1.73
Book Value
349
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Aug 14, 20250.600.600.400.4243.15K
Aug 13, 20250.500.560.470.5628.36K
Aug 12, 20250.500.500.480.5056.71K
Aug 11, 20250.500.500.470.509.58K
Aug 08, 20250.490.540.490.5412.2K
Aug 07, 20250.490.490.450.495.54K
Aug 06, 20250.490.490.450.4940.01K
Aug 05, 20250.550.550.400.4612.28K
Aug 04, 20250.550.550.470.4729.78K
Aug 01, 20250.590.590.530.5414.4K
Jul 31, 20250.600.600.540.5526.66K
Jul 30, 20250.550.650.500.5964.73K
Jul 29, 20250.600.640.430.5436.28K
Jul 28, 20250.400.580.400.57103.3K
Jul 25, 20250.380.390.350.3815.1K
Jul 24, 20250.380.380.350.358.38K
Jul 23, 20250.380.400.290.387.38K
Jul 22, 20250.360.380.320.353.8K
Jul 21, 20250.300.320.240.3217.03K
Jul 18, 20250.410.520.350.3955.11K

Contact Details

Palo Alto, CA 94303

United States

https://www.scilexholding.com650 516 4310

About Company

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company's principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase 3 clinical trial to treat lumbosacral radicular pain; SP-103 for the treatment of low back pain, which is in Phase 2 clinical trails; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia that is in Phase 1 clinical trials. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.

Company Information

Employees115
Beta1.14
Sales or Revenue$46.74M
5Y Sales Change%1.407%
Fiscal Year EndsDecember
SectorHealthcare
IndustryDrug Manufacturers - General

Stock Peers

AMGN
0.96+0.33%
Amgen Inc.$290.29BIIB
-0.26-0.19%
Biogen Inc.$134.94GILD
-1.12-0.93%
Gilead Sciences, Inc.$119.02HZNP
00
Horizon Therapeutics Public Limited Company$116.30AZN
0.53+0.68%
AstraZeneca PLC$78.47SNY
0.3+0.62%
Sanofi$49.04SCLX
-3.63-17.29%
Scilex Holding Company$17.37GRFS
0.1+0.94%
Grifols, S.A.$10.74CTOR
-0.07-3.91%
Citius Oncology, Inc.$1.72MIRA
-0.02-1.34%
MIRA Pharmaceuticals, Inc.$1.47

Frequently Asked Questions

What is the current Scilex Holding Company (SCLXW) stock price?
Scilex Holding Company (NASDAQ: SCLXW) stock price is $0.50 in the last trading session. During the trading session, SCLXW stock reached the peak price of $0.50 while $0.50 was the lowest point it dropped to. The percentage change in SCLXW stock occurred in the recent session was 18.41% while the dollar amount for the price change in SCLXW stock was $0.08.
SCLXW's industry and sector of operation?
The NASDAQ listed SCLXW is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. Scilex Holding Company designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of SCLXW?
Mr. Suketu D. Desai Ph.D.
Chief Technical Officer
Mr. Steven F. Lincoln J.D.
Interim Gen. Counsel & Chief Compliance Officer
Mr. Jaisim Shah
Pres, Chief Executive Officer & Director
Dr. Dmitri V. Lissin M.D.
Senior Vice President & Chief Medical Officer
Mr. Suresh K. Khemani
Senior Vice President & Chief Commercial Officer
Dr. Henry H. Ji Ph.D.
Executive Chairman
Ms. Elizabeth Adkins Czerepak M.B.A.
Executive Vice President, Chief Financial Officer, Chief Bus. Officer & Sec.
How SCLXW did perform over past 52-week?
SCLXW's closing price is 2.83% higher than its 52-week low of $0.50 where as its distance from 52-week high of $0.50 is -29.62%.
How many employees does SCLXW have?
Number of SCLXW employees currently stands at 115.
Link for SCLXW official website?
Official Website of SCLXW is: https://www.scilexholding.com
How do I contact SCLXW?
SCLXW could be contacted at phone 650 516 4310 and can also be accessed through its website. SCLXW operates from 960 San Antonio Road, Palo Alto, CA 94303, United States.
How many shares of SCLXW are traded daily?
SCLXW stock volume for the day was 349 shares. The average number of SCLXW shares traded daily for last 3 months was 9.96K.
What is the market cap of SCLXW currently?
The market value of SCLXW currently stands at $130.79M with its latest stock price at $0.50 and 262.01M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph